Читать книгу Protocols for High-Risk Pregnancies - Группа авторов - Страница 159

1 Berkowitz RL, Lesser ML, McFarland JG, et al. Antepartum treatment without early cordocentesis for standard‐risk alloimmune thrombocytopenia. Obstet Gynecol 2007; 110:249–55.

2 Bussel JB, Berkowitz RL, Hung C, et al. Intracranial hemorrage in alloimmune thrombocytopenia: stratified management to prevent recurrence in the subsequent affected fetus. Am J Obstet Gynecol 2010; 203(2):135.e1.

3  Kiefel V Bassler D, Kroll H, et al. Antigen‐positive platelet transfusion in neonatal alloimmune thrombocytopenia (NAIT). Blood 2006; 107(9):3761–3.

4 Lieberman L, Greinacher A, Murphy MF, et al. Fetal and neonatal alloimmune thrombocytopenia: recommednations for evidence‐based practice, an international approach. Br J Hematol 2019; 185(3):549–62.

5 Pacheco LD, Berkowitz RL, Moise KJ, et al. Fetal and neonatal alloimmune thrombocytopenia: a management algorithm based on risk stratifaction. Obstet Gynecol 2011; 118:1157–632.

6 Peterson AP, McFarland JG, Curtis BR, et al. Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis, and management. Br J Haematol 2013; 161(1):3–14.

7 Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010; 115(2):168.

8 Winkelhorst D, Murphy MF, Greinacher A, et al. Antenatal management in fetal and neonatal alloimmune thrombocytopenia: a systematic review. Blood 2017; 129:1538–47.